Advanced in Peripheral Neuropathy

Michal Mego

Bratislava, BL, SK 
Advanced in Peripheral Neuropathy
Bratislava, BL, SK 
OverviewLocationsClinical Research

Overview

Michal Mego practices in Bratislava, Slovakia. Mego is rated as an Advanced expert by MediFind in the treatment of Peripheral Neuropathy. Their top areas of expertise are Testicular Cancer, Choriocarcinoma, Teratoma of the Mediastinum, Orchiectomy, and Colostomy.

Their clinical research consists of co-authoring 185 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Peripheral Neuropathy.

Locations

Bratislava, BL, Slovakia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Phase II Study of Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer.
Phase II Study of Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer.
Enrollment Status: Withdrawn
Publish Date: October 06, 2023
Intervention Type: Drug
Study Drugs: Disulfiram, Vinorelbin, Cisplatin, Copper
Study Phase: Phase 2
Phase II Study of Disulfiram and Cisplatin in Refractory TGCTs.
Phase II Study of Disulfiram and Cisplatin in Refractory TGCTs.
Enrollment Status: Completed
Publish Date: October 04, 2023
Intervention Type: Drug
Study Phase: Phase 2
Phase II Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer
Phase II Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer
Enrollment Status: Completed
Publish Date: March 03, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Treatment Strategy of the Use of 1st Line Chemotherapy in Patients With Poor-Prognosis Disseminated Non-Seminomatous Germ Cell Tumors Based on Tumor Marker Decline: A Phase II Trial of Paclitaxel, Ifosfamid and Cisplatin Regimen.
A Treatment Strategy of the Use of 1st Line Chemotherapy in Patients With Poor-Prognosis Disseminated Non-Seminomatous Germ Cell Tumors Based on Tumor Marker Decline: A Phase II Trial of Paclitaxel, Ifosfamid and Cisplatin Regimen.
Enrollment Status: Completed
Publish Date: August 07, 2020
Intervention Type: Drug
Study Phase: Phase 2
Phase II Study of Avelumab in Multiple Relapsed/Refractory Testicular Germ Cell Cancer.
Phase II Study of Avelumab in Multiple Relapsed/Refractory Testicular Germ Cell Cancer.
Enrollment Status: Completed
Publish Date: March 05, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

185 Total Publications

Cardiovascular toxicity in testicular germ cell tumor survivors.
Cardiovascular toxicity in testicular germ cell tumor survivors.
Journal: Frontiers in oncology
Published: June 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mego's expertise for a condition
ConditionClose
View All 24 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile